Biocon subsidiary Syngene International looking to raise over $50M

Premium

Syngene International, a subsidiary of Biocon Ltd, a generics major that also owns the country's largest drug research and development services unit, is looking to raise over $50 million, at least two sources privy to the matter told VCCircle.  "This is more like a pre-IPO round," said one of the ......